OpalMedica is a MedTech company developing two complementary solutions to accelerate earlier detection of rare and underdiagnosed conditions: KLEOS™ Clinical Flags, a patent-pending Class I medical device, which helps GPs identify potential cases sooner by prompting consideration of rare conditions; and KLEOS™ My Rare Journey, a patient platform for sharing experiences and insights. Together, they inform research and improve outcomes.